Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines Across All Infectious Disease Areas
June 23, 2020 00:59 ET
|
Translate Bio, Inc.
-- The two companies will build upon their existing collaboration to pursue novel mRNA vaccines aimed at broadly addressing current and future infectious diseases -- -- Translate Bio to receive...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Moderna, Inc. (MRNA) Investors of Ongoing Investigation into Possible Securities Fraud and Insider Trading, Encourages Investors with Significant Losses to Contact Firm
June 15, 2020 16:34 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, June 15, 2020 (GLOBE NEWSWIRE) -- Hagens Berman urges investors in Moderna, Inc. (NASDAQ: MRNA) to submit their losses now to learn if they qualify to recover their investment losses....
Investitionsplan für Europa: Europäische Investitionsbank gibt BioNTech Fremdkapitalfinanzierung von bis zu 100 Millionen Euro zur Entwicklung und Herstellung eines COVID-19-Impfstoffs
June 11, 2020 03:00 ET
|
BioNTech SE
Die EIB unterstützt damit die Entwicklung von BioNTechs globalem Impfstoffprogramm BNT162 zur Prävention von COVID-19-Infektionen sowie den Ausbau der Produktionskapazitäten in Europa; beides ist Teil...
Investment Plan for Europe: European Investment Bank to provide BioNTech with up to €100 million in debt financing for COVID-19 vaccine development and manufacturing
June 11, 2020 03:00 ET
|
BioNTech SE
EIB debt instrument will support BioNTech’s global development of BNT162 for prevention of COVID-19 infection as well as scale-up of manufacturing capacity in Europe as part of the company’s global...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Announces Investigation into Moderna, Inc. (MRNA) for Possible Securities Fraud and Insider Trading, Encourages Investors with Significant Losses to Contact Firm
June 02, 2020 19:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, June 02, 2020 (GLOBE NEWSWIRE) -- Hagens Berman urges investors in Moderna, Inc. (NASDAQ: MRNA) to submit their losses now to learn if they qualify to recover their investment...
Translate Bio to Present at Jefferies Virtual Healthcare Conference
May 28, 2020 07:30 ET
|
Translate Bio, Inc.
LEXINGTON, Mass., May 28, 2020 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative...
The Law Offices of Frank R. Cruz Continues Its Investigation on Behalf of Moderna, Inc. Investors (MRNA)
May 27, 2020 10:00 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, May 27, 2020 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation on behalf of Moderna, Inc. (“Moderna” or the “Company”) (NASDAQ: MRNA) investors concerning...
The Law Offices of Frank R. Cruz Continues Its Investigation on Behalf of Moderna, Inc. Investors (MRNA)
May 21, 2020 13:15 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, May 21, 2020 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation on behalf of Moderna, Inc. (“Moderna” or the “Company”) (NASDAQ: MRNA) investors concerning...
Translate Bio to Present at the Bank of America Securities Virtual 2020 Healthcare Conference
May 12, 2020 16:05 ET
|
Translate Bio, Inc.
LEXINGTON, Mass., May 12, 2020 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative...
BioNTech Announces First Quarter 2020 Financial Results and Corporate Progress
May 12, 2020 08:05 ET
|
BioNTech SE
Global Phase 1/2 clinical trial for BNT162 vaccine program to prevent COVID-19 infection in dose escalation phase in Europe and the U.S.; first cohorts dosed in both regionsBNT122 Phase 1/2 trial...